CRC liver metastasis neoantigen discovery
downstream-application
CRC liver metastasis neoantigen discovery: downstream-application. Proteogenomics and de novo sequencing of the immunopeptidomes of patient colorectal cancer liver metastases to find HLA peptides that database search misses.
Proteogenomics and de novo sequencing of the immunopeptidomes of patient colorectal cancer liver metastases to find HLA peptides that database search misses.
| Kind | downstream-application |
| Acquisition | DDA |
| Application area | Immunopeptidomics / neoantigen |
Paper describing it
- Proteogenomics and de novo sequencing based approach for neoantigen discovery from the immunopeptidomes of patient CRC liver metastases using Mass Spectrometry (2020, The Journal of Immunology, abstract)